Teva Pharmaceuticals To Resume Production Of Scarce Childhood Cancer Drug Vincristine

Pharmaceutical company Teva USA announced today that it will resume production of childhood cancer drug vincristine after a recent shortage which led to patients missing doses of the vital chemotherapy.

Source: Forbes.com Healthcare News - November 13, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news